» Articles » PMID: 34982407

PiRNAs Interact with Cold-Shock Domain-Containing RNA Binding Proteins and Regulate Neuronal Gene Expression During Differentiation

Overview
Journal Mol Neurobiol
Date 2022 Jan 4
PMID 34982407
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

piRNAs (PIWI-interacting RNAs) are a class of small non-coding RNAs (ncRNAs) abundantly expressed in germline cells and involved in suppressing the transposon activity. Interestingly, recent studies have found piRNA expression in the central nervous system (CNS), yet the underlying biological significance remains largely unknown. In this study, we investigated the expression and function of piRNAs during the retinoic acid (RA)-mediated neuronal differentiation in NT2 cells, a human embryonal carcinoma cell line. We identified a cohort of differentially expressed piRNAs by microarray. Two piRNAs, DQ582359 and DQ596268, were increasingly upregulated during the RA-induced differentiation and involved in regulating the expression of neuronal markers, MAP2 and TUBB3. Furthermore, these piRNAs were found to associate with cold-shock domain (CSD)-containing RNA binding proteins, DIS3, DIS3L2, and YB-1. Markedly, overexpression of these piRNAs further enhanced the protein levels of MAP2 and TUBB3, potentially by downregulating DIS3, DIS3L2, and YB-1. Hence, our study has identified a novel somatic function of piRNAs in regulating neuronal gene expression. The interaction of piRNA with some CSD-containing proteins can be further explored to enhance neuronal differentiation to treat neurodegenerative diseases.

Citing Articles

piOxi database: a web resource of germline and somatic tissue piRNAs identified by chemical oxidation.

Wang K, Perera B, Morgan R, Sala-Hamrick K, Geron V, Svoboda L Database (Oxford). 2024; 2024.

PMID: 38204359 PMC: 10782149. DOI: 10.1093/database/baad096.


Role of piRNA biogenesis and its neuronal function in the development of neurodegenerative diseases.

Sato K, Takayama K, Inoue S Front Aging Neurosci. 2023; 15:1157818.

PMID: 37207075 PMC: 10191213. DOI: 10.3389/fnagi.2023.1157818.

References
1.
Lunn J, Sakowski S, Hur J, Feldman E . Stem cell technology for neurodegenerative diseases. Ann Neurol. 2011; 70(3):353-61. PMC: 3177143. DOI: 10.1002/ana.22487. View

2.
Barker R, Drouin-Ouellet J, Parmar M . Cell-based therapies for Parkinson disease—past insights and future potential. Nat Rev Neurol. 2015; 11(9):492-503. DOI: 10.1038/nrneurol.2015.123. View

3.
Subhramanyam C, Hu Q . Non-Coding RNA in Brain Development and Disorder. Curr Med Chem. 2017; 24(18):1983-1997. DOI: 10.2174/0929867324666170124151436. View

4.
Siomi M, Sato K, Pezic D, Aravin A . PIWI-interacting small RNAs: the vanguard of genome defence. Nat Rev Mol Cell Biol. 2011; 12(4):246-58. DOI: 10.1038/nrm3089. View

5.
Aravin A, Gaidatzis D, Pfeffer S, Lagos-Quintana M, Landgraf P, Iovino N . A novel class of small RNAs bind to MILI protein in mouse testes. Nature. 2006; 442(7099):203-7. DOI: 10.1038/nature04916. View